Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ETR/DMP stock hub

ETR/DMP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/DMPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.3B

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/DMP

In the news

Latest news · ETR/DMP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.6

P25 12.3P50 15.7P75 20.2

Trailing P/E18.8

P25 16.4P50 20.9P75 30.4

ROE20.2

P25 -6.7P50 8.5P75 17.2

ROIC11.1

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/DMP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

EUR

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	3,503
Employees Change	-107%
Employees Change Percent	-2.96
Enterprise value	EUR 3.1B
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	DE000A2GS5D8
Last refreshed	2026-05-10
Market cap	EUR 2.3B
Price	EUR 46.2
Price currency	EUR
Rev Per Employee	336,394.52x
Sector	Healthcare
Sic	2834
Symbol	etr/DMP
Website	https://ir.dermapharm.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.79%
EV Earnings	23.7x
EV/EBIT	13.03x
EV/EBITDA	11.36x
EV/FCF	16.78x
EV/Sales	2.66x
FCF yield	8.17%
Forward P/E	17.62x
P/B ratio	3.31x
P/E ratio	18.79x
P/S ratio	1.94x
PE Ratio10 Y	22.31x
PE Ratio3 Y	21.13x
PE Ratio5 Y	21.15x
PEG ratio	1.96x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.08%
EBITDA Margin	22.47%
FCF margin	15.87%
Gross margin	64.98%
Gross Profit	EUR 765.7M
Gross Profit Growth	2.12%
Gross Profit Growth Q	6.04%
Gross Profit Growth3 Y	5.68%
Gross Profit Growth5 Y	11.03%
Net Income	EUR 132.4M
Net Income Growth	16.37%
Net Income Growth Q	79.87%
Net Income Growth Quarters	3%
Net Income Growth Years	2%
Net Income Growth3 Y	-0.46%
Net Income Growth5 Y	9.06%
Pretax Margin	15.57%
Profit Margin	11.24%
Profit Per Employee	EUR 37,800
Profitable Years	11
ROA	6.93
Roa5y	9.36
ROCE	12.83
ROE	20.22
Roe5y	25.44
ROIC	11.09
Roic5y	14.77

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	20.7%
Cagr3y	3.88%
Cagr5y	-5.68%
Div CAGR3	-5.72%
Div CAGR5	0%
EPS Growth	16.37
EPS Growth Q	80.38
EPS Growth Quarters	3
EPS Growth Years	2
EPS Growth3 Y	-0.46
EPS Growth5 Y	9.12
FCF Growth	14.64%
FCF Growth Q	37.83%
FCF Growth3 Y	-9.16%
FCF Growth5 Y	15.68%
OCF Growth	13.79%
OCF Growth Q	31.57%
OCF Growth3 Y	-7.39%
OCF Growth5 Y	11.82%
Revenue Growth	-1.43x
Revenue Growth Q	1.44x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	4.23x
Revenue Growth5 Y	7.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.55
Assets	EUR 2.2B
Cash	EUR 204.5M
Current Assets	EUR 702.9M
Current Liabilities	EUR 342.9M
Debt	EUR 1.1B
Debt EBITDA	EUR 3.89
Debt Equity	EUR 1.53
Debt FCF	EUR 5.66
Equity	EUR 690.8M
Interest Coverage	4.86
Liabilities	EUR 1.5B
Long Term Assets	EUR 1.5B
Long Term Liabilities	EUR 1.2B
Net Cash	EUR -853.5M
Net Cash By Market Cap	EUR -37.29
Net Debt EBITDA	EUR 3.22
Net Debt Equity	EUR 1.24
Net Debt FCF	EUR 4.56
Tangible Book Value	EUR -271.8M
Tangible Book Value Per Share	EUR -5.05
WACC	7.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.05
Inventory Turnover	1.23
Net Working Capital	EUR 290.5M
Quick ratio	0.95
Working Capital	EUR 360M
Working Capital Turnover	EUR 3.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-2.22%
Dividend Growth Years	1%
Dividend per share	EUR 0.88
Dividend Years	8
Dividend Yield	1.9%
Ex Div Date	2026-06-29
Last Dividend	EUR 0.88
Payout Frequency	Annual
Payout Ratio	36.59%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	20.68%
200-day SMA	36.95
3Y total return	12.09%
50-day SMA	43.12
50-day SMA vs 200-day SMA	50over200
5Y total return	-25.36%
All Time High	91.95
All Time High Change	-49.76%
All Time High Date	2022-01-03
All Time Low	21.58
All Time Low Change	114.14%
All Time Low Date	2018-12-20
ATR	1.26
Beta	0.86
Beta1y	0.5
Beta2y	0.53
Ch YTD	17.41
High	47.15
High52	47.8
High52 Date	2026-05-06
High52ch	-3.35%
Low	46.1
Low52	31.7
Low52 Date	2025-09-25
Low52ch	45.74%
Ma50ch	7.14%
Price vs 200-day SMA	25.03%
RSI	57.63
RSI Monthly	61.29
RSI Weekly	73.02
Sharpe ratio	0.63x
Sortino ratio	1.12
Total Return	1.9%
Tr YTD	17.41
Tr1m	7.19%
Tr1w	0.43%
Tr3m	27.1%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 236.6M
Operating Income Growth	6.55
Operating Income Growth Q	9.09
Operating Income Growth3 Y	-5.76
Operating Income Growth5 Y	11.05
Operating margin	20.08

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,465,810%
Net Borrowing	61,778,000
Shares Insiders	7.38%
Shares Institutions	11.9%
Shares Out	49,540,810
Shares Qo Q	-1.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 187M
Average Volume	16,884.4x
Bv Per Share	12.9
CAPEX	EUR -42.1M
Ch1m	7.19
Ch1w	0.43
Ch1y	17.56
Ch3m	27.1
Ch3y	4.2
Ch5y	-34.56
Ch6m	40
Change	0%
Change From Open	-2.01
Close	46.2
Days Gap	2.06
Depreciation Amortization	28,119,000
Dollar Volume	534,534
Earnings Date	2026-05-13
EBIT	EUR 236.6M
EBITDA	EUR 264.7M
EPS	EUR 2.46
F Score	6
FCF	EUR 187M
FCF EV Yield	5.96x
FCF Per Share	EUR 3.78
Financing CF	-46,106,000
Fiscal Year End	December
Founded	1,991
Goodwill	587,059,000
Graham Number	26.71453
Graham Upside	-42.18
Income Tax	EUR 52.2M
Investing CF	-98,240,000
Is Primary Listing	1
Last Earnings Date	2026-03-10
Last Report Date	2025-12-31
Lynch Fair Value	EUR 22.28
Lynch Upside	-51.78
Ma150	38.21
Ma150ch	20.92%
Ma20	45.83
Ma20ch	0.81%
Net CF	82,115,000
Next Earnings Date	2026-05-13
Open	47.15
P FCF Ratio	12.24
P OCF Ratio	9.99
Payment Date	2026-07-01
Position In Range	9.52
Ppne	318,542,000
Price Date	2026-05-08
Price EBITDA	EUR 8.65
Relative Volume	0.69x
Revenue	1,178,390,000x
Tax By Revenue	4.43x
Tax Rate	28.42%
Tr6m	40%
Volume	11,570
Z Score	2.2

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/DMP dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.9%

$0.88 annual per share

Payout ratio

+36.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

0.0%

1 consecutive years of growth

Total shareholder yield

+1.9%

Next ex-dividend date: 2026-06-29

Performance

ETR/DMP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/DMP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.9%

Share of float held by funds and institutions

Insider ownership

+7.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

ETR/DMP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.6

Neutral momentum band

Price vs 200-day MA

+25.0%

50/200-day relationship not available

Beta (5Y)

0.86

Moves roughly with the market

Sharpe ratio

0.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/DMP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/DMP stock rating?

etr/DMP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/DMP analysis?

The full report lives at /stocks/etr/DMP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/DMP?

The latest report frames etr/DMP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/DMP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.